Synthesis and structural characteristics of metal–acyclovir (ACV) complexes: [Ni(or Co)(ACV)₂(H₂O)₄]Cl₂·2ACV, [Zn(ACV)Cl₂(H₂O)], [Cd(ACV)Cl₂]·H₂O and [{Hg(ACV)Cl₂}_x]. Recognition of acyclovir by Ni–ACV

Abstract

The monomeric [M(ACV)₂(H₂O)₄]Cl₂·2ACV (M = Ni^II 1 or Co^II 2), [Zn(ACV)Cl₂(H₂O)] 3 and the polymeric [Cd(ACV)Cl₂]·H₂O 4 [ACV = acyclovir = 9-(2-hydroxymethoxymethyl)guanine] complex have been prepared and characterised by X-ray diffraction and IR data; ¹H and ¹³C NMR have been used to interpret the structural characteristics of the complexes in solution. Compounds 1 and 2 exist as octahedral complexes with four H₂O ligands in the basal plane [Ni–OW 2.053(2) and 2.057(7) Å] and two axial ACV molecules linked to Ni through N(7) [Ni–N(7) 2.160(2) Å]. Two additional ACV molecules are included in the outer sphere of the complex, interacting by means of hydrogen bonds with the co-ordinated ACVs. This reveals the unprecedented recognition of free acyclovir molecules by Ni(or Co)-ACV (1 and 2). The monomeric zinc(II) complex 3 exhibits a distorted-tetrahedral geometry, involving two chlorides, the N(7) of the ACV ligand [Zn–N(7) 2.009(2) Å] and a water molecule. The hydrogen bonding of two guanine bases via NH₂ and N(3) (unit 1) with N(3) and NH₂ (unit 2) represents a novel type of interaction between nucleobases. In the case of the cadmium(II) complex 4 the structure is built by polymeric (CdCl₂)_n chains which are held together by ACV ligands. The cadmium cation is octahedrically coordinated by four chlorides, the N(7) from an ACV molecule and the hydroxylic oxygen from another ACV molecule, the latter two atoms being placed in cis disposition. On the other hand, the complex [{Hg(ACV)Cl₂}_x] 5 can be tentatively assigned as a polymer by comparison with analogous guanosine systems and spectroscopic and conductometric data.

References

1. H. J. Schaeffer, L. Beauchamp, P. de Miranda, G. B. Elion, D. J. Bauer and P. Collins, Nature, 1978, 272, 583.
2. J. A. Fyfe, P. M. Keller, P. A. Furman, R. L. Miller and G. B. Elion, J. Biol. Chem., 1978, 253, 8721; G. B. Elion, J. Antimicrob. Chemother., 1983, 12, Suppl. B, 9.
3. R. B. Silverman, in The Organic Chemistry of Drug Design and Drug Action, Academic Press, New York, 1992, p. 392; C. J. Coulson, in Molecular Mechanisms of Drug Action, 2nd edn., Taylor & Francis, London, 1994, p. 30.
4. P. J. Sadler, Adv. Inorg. Chem., 1991, 36, 1.
5. S. Grabner and N. Bukovec, 4th FGIPS Meeting in Inorganic Chemistry, European Mediterranean Conference in Inorganic Chemistry, Corfu, October 1997, Abstract PA32.
6. Z. Balcarova, J. Kasparkova, G. Natile and V. Brabec, 4th FGIPS Meeting in Inorganic Chemistry, Corfu, October 1997, Abstract ORA 20.
7. L. Cavallo, R. Cini, J. Kobe, L. G. Marzilli and G. Natile, J. Chem. Soc., Dalton Trans., 1991, 1867.
8. I. Turel, I. Leban and K. Gruber, J. Inorg. Biochem., 1996, 63, 41.
9. B. Blazic, I. Turel, N. Bukovec, P. Bukovek and F. Lazarini, J. Inorg. Biochem., 1993, 51, 737.
10. (a) B. Andersen, T. I. Sjastad, I. Turel, A. Emwas, E. Sletten, C. A. Blindauer and H. Sigel, COST D8 — Chemical Properties of Platinum and Other Metal Ion Complexes with Nucleobases and Antiviral Nucleotide Analogues. Dortmund, September 1998; (b) I. Turel, N. Bukovec, M. Goodgame and D. J. Williams, Polyhedron, 1997, 16, 1701.
11. G. M. Sheldrick, SHELXTL Version 5 for PC, Siemens Analytical X-ray Instruments, Inc., Madison, WI, 1994.
12. K. Aoki, Bull. Chem. Soc. Jpn., 1975, 48, 1260; G. R. Clark and J. D. Orbell, J. Chem. Soc., Chem. Commun., 1974, 139.
13. J. J. Fiol, A. Terrón, A. M. Calafat, V. Moreno, M. Aguiló and X. Solans, J. Inorg. Biochem., 1989, 35, 191.
14. P. de Meester, D. M. L. Goodgame, A. C. Skapski and B. T. Smith, Biochem. Biophys. Acta, 1974, 340, 113.
15. N. S. Begum, M. D. Poojary and H. Manohar, J. Chem. Soc., Dalton Trans., 1988, 1303.
16. R. W. Gellert, J. K. Shiba and R. Bau, Biochem. Biophys. Res. Commun., 1979, 88, 1449.
17. G. I. Birnbaum, M. Cygler and D. Shugar, Can. J. Chem., 1984, 62, 2646.
18. R. K. O. Sigel, E. Freisinger and B. Lippert, Chem. Commun., 1998, 219; R. K. O. Sigel, E. Freisinger, S. M. Thompson and B. Lippert, COST D8 — Chemical Properties of Platinum and Other Metal Ion Complexes with Nucleobases and Antiviral Nucleotide Analogues, Dortmund, September 1998.
19. P. de Meester, D. M. L. Goodgame, T. J. Jones and A. C. Skapski, Biochem. Biophys. Acta, 1974, 353, 392.
20. S. K. Miller, D. G. VanDerveer and L. G. Marzilli, J. Am. Chem. Soc., 1985, 107, 1048.
21. K. Aoki, Acta Crystallogr., Sect. B, 1976, 32, 1454.
22. (a) A. Bonamartini, M. R. Cramarossa and M. Saladini, Inorg. Chim. Acta, 1997, 257, 19; (b) E. A. H. Griffith, N. G. Charles and E. L. Amma, Acta Crystallogr., Sect. B, 1982, 38, 942.
23. H. A. Tajmir-Riahi and T. Theophanides, Can. J. Chem., 1984, 62, 1429.
24. M. Tsuboi, S. Takahoshi and I. Harada, in Physicochemical Properties of Nucleic Acids, ed. J. Duchesne, Academic Press, New York, 1973, vol. 2, p. 91; H. A. Tajmir-Riahi and T. Theophanides, Inorg. Chim. Acta, 1983, 80, 223; D. U. Young, P. Tollin and H. R. Wilson, Acta Crystallogr., Sect. B, 1974, 30, 2012; T. Theophanides and H. A. Tajmir-Riahi, in Spectroscopy of Biological Molecules, eds. C. Sandorfy and T. Theophanides, D. Reidel, Dordrecht, 1982, p. 137; S. Shirotake and T. Sakaguchi, Chem. Pharm. Bull., 1978, 26, 2941.
25. H. A. Tajmir-Riahi and T. Theophanides, Can. J. Chem., 1985, 63, 2065.
26. K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Wiley, New York, 1978.
27. N. B. Behrens and D. M. L. Goodgame, Inorg. Chim. Acta, 1980, 46, 15.
28. M. Quirós, J. M. Salas-Peregrín, M. P. Sánchez-Sánchez and R. Fauré, An. Quim., 1990, 86, 518.